Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003024455A3 Stent coated with a sustained-release drug delivery and method for use thereof
10/30/2003WO2003022243A3 Sustained release of microcrystalline peptide suspensions
10/30/2003WO2003020320A3 Nanoparticles comprising biologically active tnf which is immobilised on the same
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003014305A3 Eukaryotic cells and method for preserving cells
10/30/2003WO2003013610A3 Surfactant compounds and uses thereof
10/30/2003WO2003008628A3 Enzymatic nucleic acid peptide conjugates
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002087563A3 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
10/30/2003WO2002087498A3 Diagnostic imaging compositions, their methods of synthesis and use
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002080978A3 Pharmaceutical compositions comprising ascomycin
10/30/2003WO2002064162A3 Vaccine for transcutaneous immunization
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003WO2002060406A8 Veterinary dermatologic composition
10/30/2003WO2002060405A8 Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative
10/30/2003WO2002056916A3 Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
10/30/2003WO2002020090A9 Pharmaceutical compositions
10/30/2003US20030204206 Electrically responsive promoter system
10/30/2003US20030204180 Temperature responsive delivery systems
10/30/2003US20030204057 Chemically modified G-CSF
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030204037 Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
10/30/2003US20030203976 Anti-angiogenic compositions and methods of use
10/30/2003US20030203961 A taxane joined by a hydrolyzable bond to one or more oligomers that containing a polyethylene glycol group and a tert-amide group
10/30/2003US20030203958 Therapeutic inhibitor of vascular smooth muscle cells
10/30/2003US20030203953 Repinotan kit
10/30/2003US20030203943 A chemical complex of niacinamide and H2 histamine receptor antagonist which is selected from ranitidine, cimetidine, famotidine, nizatidine and derivatives; a medicament or a dietary- supplement for immunomodulation in a mammal
10/30/2003US20030203931 Polymorph of a pharmaceutical
10/30/2003US20030203930 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/30/2003US20030203878 Comprises non-hydrated hydrogel, superdisintegrant, and tannic acid; for treatment of metastatic bone diseases (hypercalcemia)
10/30/2003US20030203876 Comprises epothilone in form of infusion concentrate or lyophilised composition
10/30/2003US20030203875 Comprises artesunic acid complexed with cyclodextrins, which shields peroxide portion of artemisinin backbone from hydrolytic decomposition; for treatment of malaria
10/30/2003US20030203874 Revitalization formulation
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203836 Methods for reduced renal uptake of protein conjugates
10/30/2003US20030203415 Comprises polypeptide for, diagnosis, detection and treatment of cancer
10/30/2003US20030203359 Polyamide-oligonucleotide derivatives, their preparation and use
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203048 Oral administration to counteract dehydration resulting from vomiting, diarrhea, physical exercise or illness; especially suitable for infants, small children and the elderly; water, sodium, potassium, citrate, carbonate and structuring
10/30/2003US20030203046 Solutions and aerosols of metal-containing compounds
10/30/2003US20030203044 Wound-treating gel
10/30/2003US20030203041 Fungus inhibiting biological compound
10/30/2003US20030203038 Targeted delivery of bioactive factors to the systemic skeleton
10/30/2003US20030203037 Dosage forms which can be administered parenterally and comprise a suspension of the salt of tramadol and diclofenac
10/30/2003US20030203034 Compositions for treating hyperemia
10/30/2003US20030203033 Biodegradation organophosphorus polymer; administering to tumor in situ
10/30/2003US20030203032 Dilute aqueous solution containing epidermal growth factor in gel
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030203026 Compressed tablet containing non-steroid antiinflammatory drug
10/30/2003US20030203025 Sustained release oral formulations
10/30/2003US20030203024 Hydrogel-forming sustained-release preparation
10/30/2003US20030203022 Quick disintegrating tablet in buccal cavity and production process thereof
10/30/2003US20030203020 Pharmaceutical compositions for piperidinoalkanol compounds
10/30/2003US20030203019 Coated conditioners for use in foods and pharmaceuticals
10/30/2003US20030203018 Stable oral pharmaceutical dosage forms
10/30/2003US20030203013 Microbial cellulose wound dressing for treating chronic wounds
10/30/2003US20030203007 Pharmaceutical composition reduced in bitter taste and the like
10/30/2003US20030203006 Immunomodulator
10/30/2003US20030203003 Drug releasing biodegradable fiber implant
10/30/2003US20030203001 Drug delivery; analgesics, antiinflammatory agents; contacting skin with hydrogel containing drugs
10/30/2003US20030202995 Transdermal drug delivery
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202985 Methods and compositions for immunotherapy of cancer
10/30/2003US20030202981 Chimeric hybrid analgesics
10/30/2003US20030202979 Mixture of lecithin and polymer
10/30/2003US20030202978 Spray freeze-dried compositions
10/30/2003US20030202959 Polymeric acyl derivatives of indoles
10/30/2003US20030202955 Crosslinked polyether binding to protein; biodegradation
10/30/2003US20030202942 Membrane forming lipid containing contrast agent; medical diagnosis
10/30/2003US20030202939 Forming oxygen free radicals; destroying tumor, cancer
10/30/2003US20030202938 Hematopoietic growth factor inducible neurokinin-1 gene
10/30/2003CA2770411A1 Aerosol containing a particulate active substance
10/30/2003CA2522550A1 Delivery systems for functional ingredients
10/30/2003CA2482924A1 Adjuvant enhanced immunotherapy
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482719A1 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003CA2482717A1 Polymorph of ascomycin derivative
10/30/2003CA2482477A1 Synthetic glyco-lipo-peptides as vaccines
10/30/2003CA2482464A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003CA2482249A1 Dry powder inhalant composition
10/30/2003CA2482029A1 Peptide deformylase activated prodrugs
10/30/2003CA2481972A1 Methods of treating ileus
10/30/2003CA2481753A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003CA2481749A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/30/2003CA2481524A1 Method of inhibiting restenosis
10/30/2003CA2481507A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2481467A1 Dry powder compositions
10/29/2003EP1357132A2 Detection of the her2 receptor by means of biotinylated humanized antibody
10/29/2003EP1356826A1 Microparticles comprising carbohydrate beads covalently linked with allergen
10/29/2003EP1356825A1 Process for producing aqueous cellulose derivative dispersion
10/29/2003EP1356822A2 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356814A1 Pharmaceutical emulsion preparation
10/29/2003EP1356813A1 Antibacterial compositions comprising metal phthalocyanine analogues
1 ... 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 ... 1712